Amgen Must Face Regeneron's Bundling Antitrust Suit

Amgen Must Face Regeneron’s Bundling Antitrust Suit

Source Node: 2023454
By Nadia Dreid (March 21, 2023, 6:30 PM EDT) — Amgen can’t escape a lawsuit accusing it of using a bundling scheme to increase the sales of its cholesterol drug Repatha and push competitors out of the market, a Delaware federal judge has ruled….

Time Stamp:

More from Law 360